Table 2

Yearly changes in FEV₁ and DL_CO before and after pregnancy

Subject	FEV₁ (% pred)	DL_CO (% pred)	∆FEV₁ (mL/year)		∆FEV₁ (%/year)		∆DL_CO (mL/min/ mm Hg/year)		∆DL_CO (%/year)
Pregnancy	Before		Before	After	Before	After	Before	After	Before	After
2	1.6 (53)	13 (48)	−231	−198	−6.8	−5.99	−1.76	−1.55	−5.9	−3.9
3	2.6 (77)	20 (82)	−184	−284	−4.7	−7.9	−0.99	−0.93	−2.9	−2.6
4	2.8 (78)	18 (57)	−29	−173	−0.27	−4.2	−0.3	−0.71	−0.69	−2.0
5	2.5 (76)	18 (66)	−546	−315	−17.8	−10.2	−3.3	−2.59	−11.8	−9.3
8	3.4 (102)	17 (57)	−227	−420	−6.0	−11.9	–	–	–	–
9	2.8 (96)	19 (72)	−37	−66	−0.46	−1.5	0.78	−0.99	−3.29	3.3
10	3.3 (115)	29 (132)	50	−48	10.8	−0.87	3.7	-2	17.1	−8.6
12	2.8 (98)	19 (89)	−44	−95	−0.7	−2.6	−0.66	−0.78	−2.5	−3.2
13	3.4 (104)	–	21	−252	−0.9	−4.7	–	–
14	2.1 (62)	15 (63)	−84	−151	−1.8	-4	−0.53	−0.81	−1.88	−3.0
15	1.7 (64)	11 (53)	−96	−165	−2.6	−5.6	−1.17	−0.96	−4.8	−4.2
16	2.0 (83)	17 (87)	−43	−157	−0.7	−6.0	−0.24	−0.98	−0.6	−4.3

Data shown only include measurements taken when not receiving an mTOR inhibitor. Subject numbers correspond to table 1 and the figure 1. ∆FEV₁ rate of change of FEV₁ (mL/year) and per cent predicted/year (%/year). ∆DL_CO rate of change of DL_CO (mL/min/mm Hg/year).
FEV₁, forced expiratory volume in 1 s.